Open positions

November 29, 2021

Postdoctoral Position available in the Phillip (tiME)n lab

We are seeking a motivated postdoctoral researcher interested in the intersection of bioengineering and translational ageing research. Projects are based on defining the multiscale dependence of ageing in the context of health and disease. These include developing cell-based biomarkers of ageing and developing a framework to define how ageing rates change and manifest across length scales (i.e. molecular, cellular, clinical and populations). The long term goal of these studies are to develop pathways for modifiable aging trajectories.

The successful candidate will take advantage of this NIH T32 funded position, a competitive salary and a rich academic environment, with opportunities to learn from and collaborate with leading researchers in engineering, medicine, public health and more.

Trainees will also be able to take advantage of career development and educational programs available within the institute for NanoBiotechnology (INBT) as well as within the Departments of Biomedical Engineering (JHU BME) and Chemical and Biomolecular Engineering (JHU ChemBE).

Interested candidates with an advanced degree in areas related to bioengineering, biomedical sciences, biomedical data science having interest in translational aging research are encouraged to apply. Please send your updated CV, cover letter and the contact information for three references to Dr. Jude Phillip at [email protected]. Inquiries about the position are also welcomed.


Jude M. Phillip, PhD.

Assistant Professor of Biomedical Engineering

Secondary appointment in Chemical and Biomedical Engineering

Core Researcher in the Institute for Nanobiotechnology (INBT)


Postdoctoral position available in the Gerecht lab
The Gerecht laboratory has a new opening for an innovative PhD graduate to conduct vascular development bioengineering research beginning summer 2018. The ideal candidate for this position will have extensive experience in vascular biology and development, while considering novel approaches to encouraging stem cells to repair and/or regenerate due to injury or disease. Experience working with vascular differentiation and hPSCs is a plus.Dr. Sharon Gerecht is the director of Johns Hopkins University’s Institute for NanoBioTechnology and a professor with joint appointments in ChemBE, MatSci, and the Sidney Kimmel Cancer Center. Her research focuses primarily on vascular repair and regeneration using stem cells and engineering cancer therapies. Interested candidates should email a cover letter describing their career goals, a copy of their CV, and names of three references to s[email protected]. Applicants are encouraged to propose a new project that interests them. This is a minimum two-year position, funded according to NIH guidelines and JHU employment policies.

Postdoctoral opening in biomimetic microfluidic platforms for hypertension 

Immediate opening for a postdoctoral fellow to work on the development and characterization of biomimetic tissue constructs for investigating vascular diseases. Expertise is required in one or all of the following: photo and soft-lithography, microfluidics, cell culture, and tissue engineering. Postdoctoral fellows will have a unique opportunity to do interdisciplinary research at the interface of engineering (Prof. Gracias’s lab) and medicine (Prof. Lewis Romer), and publish their results in high impact journals. We are seeking highly motivated and well published researchers with good oral and written communication skills. Please email resumes to Prof. David Gracias ([email protected]).

Postdoctoral Positions Available in Wirtz Lab

Multiple postdoctoral positions are available to study the role of the synergistic mechanism of Interleukin 6 and 8 in cell density-dependent mechanisms that govern metastasis in the Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD.

Proliferation and migration are two key drivers of metastasis that can be mechanistically coupled in the tumor microenvironment through local tumor cell density via the synergistic signaling of Interleukin 6 and 8. Inhibition of this mechanism in pre-clinical mouse models has demonstrated a decrease in metastatic burden to the lungs, liver, and lymph nodes. We are now further delineating this signaling mechanism to develop better therapeutics against cancer metastasis.

Please see our recent publications and webpage for detail: 

Competitive Salary and excellent work environment are offered. Self-motivated individuals with an advanced degree in any area of biomedical sciences and specially those who are skilled in immunobiology or bioinformatics are encouraged to apply.  Please send CV and names of three references to:

Denis Wirtz PhD. [email protected]

Vice Provost for Research
TH Smoot Professor, Chemical and Biomolecular Engineering, Pathology, Oncology

Director Johns Hopkins Physical Sciences-Oncology Center
Johns Hopkins University and Johns Hopkins School of Medicine
3400 N. Charles St.
Baltimore, MD 21218

Back to top